Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature (Q26769661)

Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature

19 September 2019

adverse drug reaction

1 reference

23 November 2020

1 reference

1 reference

corrigendum / erratum

0 references

3

Jeffrey K Aronson

0 references

author name string

Igho J Onakpoya

series ordinal

1

0 references

Carl J Heneghan

series ordinal

2

0 references

language of work or name

English

0 references

publication date

2016

0 references

4 February 2016

2 references

19 September 2019

23 November 2020

2 references

19 September 2019

23 November 2020

14

0 references

page(s)

10

0 references

issue

1

0 references

copyright license

Creative Commons Attribution 4.0 International

2 references

Europe PubMed Central

19 September 2019

https://scigraph.springernature.com/pub.10.1186/s12916-016-0553-2

Europe PubMed Central

23 November 2020

0 references

0 references

cites work

Delays in the post-marketing withdrawal of drugs to which deaths have been attributed: a systematic investigation and analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740994

Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740994

WITHDRAWN--a resource for withdrawn and discontinued drugs

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740994

Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740994

Specific features of medicines safety and pharmacovigilance in Africa

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740994

An investigation into drug products withdrawn from the EU market between 2002 and 2011 for safety reasons and the evidence used to support the decision-making

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740994

New drug approval times and safety warnings in the United States and Canada, 1992-2011.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740994

Underreporting of side effects of standard first-line ART in the routine setting in Blantyre, Malawi

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740994

Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740994

The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740994

Withdrawal of cerivastatin revealed a flaw of post-marketing surveillance system in the United States

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740994

Case reports of suspected adverse drug reactions--systematic literature survey of follow-up

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740994

Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740994

A comparative analysis of drug safety withdrawals in the UK and the US (1971-1992): implications for current regulatory thinking and policy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740994

Equity and health sector reforms: can low-income countries escape the medical poverty trap?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740994

Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740994

Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740994

Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region).

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740994

Medicine Vendors: Self-medication Practices and Medicine Knowledge

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740994

Hazardous drugs in developing countries

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740994

Reconciling informed consent with prescription drug requirements

31 May 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0553-2

Africa struggles to improve drug safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0553-2

The lack of knowledge about the voluntary reporting system of adverse drug reactions as a major cause of underreporting: direct survey among health professionals

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0553-2

Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0553-2

An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0553-2

Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0553-2

Self medication practices among workers in a tertiary hospital in Nigeria.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740994

Underreporting of adverse drug reactions: attitudes of Irish doctors

28 November 2018

1 reference

12 December 2020

Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions

1 reference

12 December 2020

An Educational Intervention to Improve Physician Reporting of Adverse Drug Reactions

1 reference

12 December 2020

Understanding drug safety and how to maximize it for patients

1 reference

12 December 2020

The impact of direct healthcare professional communication on prescribing practice in the UK hospital setting: an interrupted time series analysis

1 reference

12 December 2020

A pharmaceutical manufacturer's perspective on reporting adverse drug experiences

1 reference

12 December 2020

Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions

1 reference

12 December 2020

Drug discontinuations in the United Kingdom and the United States, 1964 to 1983: issues of safety

1 reference

12 December 2020

Evaluation of the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets-1960 to 1999

1 reference

https://api.crossref.org/works/10.1186%2FS12916-016-0553-2

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1186/S12916-016-0553-2

1 reference

Dimensions Publication ID

2813256

1051507374

0 references

2813256

1 reference

1 reference

1 reference